Key Takeaways:
Wise Group plc shares fell 16.05 percent over three sessions after Belgian authorities opened a criminal probe into the fintech's anti-money laundering and counter-terrorist financing controls, a gap the class action alleges was understated before its NASDAQ debut.
"The Belgian probe is the trigger that exposed the gap between what Wise told investors and what regulators were documenting," said Josh Wilson, securities litigation partner at Faruqi & Faruqi LLP, which is investigating claims against the company.
The class action covers investors who purchased WSE securities between May 11 and July 23, 2026. Shares opened at $13.04 on Aug. 28, down from a 52-week high of $17.47, with a 50-day moving average of $12.44. The company reported $0.12 EPS on $576.48 million revenue for the quarter ended June 25.
The September 29 deadline to seek lead-plaintiff status carries direct financial stakes: legal costs, potential damages, and regulatory penalties could compound the losses already absorbed by shareholders. Analysts still hold a Moderate Buy consensus with an average target of $16.52, but the litigation cloud hangs over that outlook.
The complaint alleges that Wise and its executives violated federal securities laws by making false or misleading statements about the company's regulatory position. Specifically, the suit claims defendants materially understated Wise's regulatory risks from deficient anti-money laundering efforts and insufficient measures to prevent terrorist financing, in order to secure a successful NASDAQ debut.
The allegations center on regulators documenting "long-standing deficiencies" at Wise's U.S. operations while the company represented compliance with AML and CTF requirements. The claims have not been proven in court, and Wise has not yet filed a response to the complaint.
The litigation has drawn attention from multiple securities law firms. Faruqi & Faruqi, SBS, Kaplan Fox, and Rosen Law Firm have all issued investor alerts regarding the September 29 lead-plaintiff deadline. The court-appointed lead plaintiff will be the investor with the largest financial interest in the relief sought who is adequate and typical of class members.
Institutional investors who entered positions during the second quarter now face potential losses. Thornburg Investment Management acquired 168,669 shares valued at approximately $2,009,000, while Royal London Asset Management purchased a $2,514,000 stake. Public Employees Retirement System of Ohio, Van ECK Associates, and Madison Asset Management also established new positions during the period.
Analyst sentiment remains cautiously constructive despite the legal pressure. Barclays raised Wise Group to a "strong-buy" rating on July 7, and Goldman Sachs upgraded the stock to "strong-buy" on May 12. JPMorgan reduced its price target from $17.50 to $17.30 with an "overweight" rating on July 17, while BNP Paribas Exane initiated coverage with an "outperform" rating and a $16.69 target on June 1. The consensus average target of $16.52 implies roughly 27 percent upside from current levels — if the litigation resolves without catastrophic findings.
The stock's 52-week range of $10.36 to $17.47 shows how far the probe has pushed the shares from their highs. With a debt-to-equity ratio of 0.17 and a current ratio of 1.07, the balance sheet remains stable, but the legal overhang is a separate risk that fundamentals cannot offset. If the Belgian probe escalates into formal penalties, the class action could expand beyond its current class period, and the stock could test the $10.36 low. If the probe is resolved without material findings, the shares could recover toward the analyst consensus target.
Wise Group's annual general meeting is scheduled for September 24, five days before the lead-plaintiff deadline. The company has not yet disclosed any remediation plans for its AML/CTF compliance programs or the potential financial impact of the Belgian probe.
This article is for informational purposes only and does not constitute investment advice.
